GSR, a key player in crypto’s capital markets, has invested $100 million in MEI Pharma, Inc., solidifying Litecoin (LTC) as a treasury asset. Charlie Lee, Litecoin creator, will work with GSR, joining MEI’s Board of Directors to bridge public markets and crypto innovation, enhancing LTC’s institutional credibility.

MEI Pharma’s strategic partnership with GSR marks the first time a public company aligns its treasury strategy with Litecoin at an institutional level. This move signals growing institutional confidence in LTC’s stability, regulatory clarity, and long-term potential, with GSR managing LTC as a treasury asset.

With GSR’s involvement as an investor, strategic advisor, and asset manager, the partnership sets the stage for LTC’s growth in decentralized finance. Lead investors include Charlie Lee and GSR, with support from the Litecoin Foundation, crypto venture capital firms, and other financial institutions, aiming to enhance LTC’s utility and accessibility.

GSR’s investment in MEI Pharma underscores its commitment to the digital asset ecosystem, offering capital solutions, liquidity, and strategic advisory services to partners at all stages of growth. This collaboration highlights the increasing institutional interest in Litecoin and the expanding role of digital assets in traditional markets, driving further growth and innovation in the industry.

Read more at Yahoo Finance: GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee